MTE #30 - Management of Liver Disease after HCV Cure

Nov 12 2023

Room 202 - Hynes Convention Center

12:30 - 1:15 PM EST

Speakers

Jordan J. Feld

Toronto Centre for Liver Disease/Viral Hepatitis Care Network (VIRCAN), University Health Network

Harrys A. Torres

The University of Texas MD Anderson Cancer Center

Description

The purpose of this session is to discuss management of co-morbid viral and liver disease in patients living with hepatitis C. The experts will discuss their approach to hepatitis C treatment and post-treatment management in patients with concomitant HIV, hepatitis B virus, steatotic liver disease (SLD), or HCC.

Objectives

To identify modifiable risk factors for liver disease progression after hepatitis C cure
To describe the management of patients with hepatitis C and HIV and/or hepatitis B coinfection